Post

Clinical trials today are highly bureaucratic, expensive, and time-consuming. Most trials fail to recruit enough participants to answer their questions at all. This great post by Adam Kroetsch explains how things got this way. www.clinicaltrialsabundance.blog/p/clinical-t...

What's most interesting to me is that rigour doesn't have to mean bureaucracy. For decades, some researchers have been pushing for larger, simpler, more efficient trials that are arguably more rigorous than their bureaucratic counterparts.

I'm a fan of this model. While there are sometimes trade-offs between rigorous practices and speed, there are also many win-win ideas that mean we don't need to compromise at all, and we can improve both at once.